user

Efficacy and safety of natalizumab extended interval dosing

被引：0
|
作者：
Zeineddine, M. [1 ]
Ayyoubi, N. [1 ]
Tamim, H. [2 ]
Nicolas, J. [3 ]
Khoury, S. [1 ]
Yamout, B. [1 ]
机构：
[1] Amer Univ Beirut, Med Ctr, Nehme & Therese Tohme Multiple Sclerosis Ctr, Beirut, Lebanon
[2] Clin Res Inst, Beirut, Lebanon
[3] Amer Univ Beirut, Beirut, Lebanon
来源：
MULTIPLE SCLEROSIS JOURNAL | 2017年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP1655
引用
收藏
页码：871 / 871
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of natalizumab extended interval dosing
    Yamout, Bassem, I
    Sahraian, Mohamad Ali
    El Ayoubi, Nabil
    Tamim, Hani
    Nicolas, Johnny
    Khoury, Samia J.
    Zeineddine, Maya M.
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2018, 24 : 113 - 116
  • [2] Efficacy and safety of natalizumab extended interval dosing
    Zeineddine, Maya
    Ayyoubi, Nabil
    Tamim, Hani
    Nicolas, Johny
    Khoury, Samia
    Yamout, Bassem
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : NP22 - NP23
  • [3] Extended interval dosing of natalizumab: is efficacy preserved?
    Clerico, M.
    Signori, A.
    De Mercanti, S.
    Cordioli, C.
    Signoriello, E.
    Lus, G.
    Maniscalco, G. T.
    Curti, E.
    Lorefice, L.
    Cocco, E.
    Nociti, V.
    Mirabella, M.
    Baroncini, D.
    Landi, D.
    Mataluni, G.
    Petruzzo, M.
    Lanzillo, R.
    Gandoglia, I.
    Laroni, A.
    Frangiamore, R.
    Sartori, A.
    Cavalla, P.
    Costantini, G.
    Sormani, M. P.
    Capra, R.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 282 - 283
  • [4] Safety of extended interval dosing of Natalizumab in clinical practice
    Pastor, S.
    Fernandez-Fournier, M.
    Sastre Real, M.
    Perez Lucas, J.
    Puertas Munoz, I.
    Tallon, A.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 335 - 336
  • [5] Effectiveness of natalizumab in extended dosing interval
    Ramo-Tello, C.
    Grau-Lopez, L.
    Vilaro, L.
    Segui, C.
    Delicado, S.
    Bonafont, X.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 213 - 214
  • [6] Effectiveness of Natalizumab in Extended Dosing Interval
    Hervas, Jose Vicente
    Punet-Ortiz, Joan
    Teniente-Serra, Aina
    Mansilla, M. Jos
    Quirant-Sanchez, Bibiana
    Navarro, Juan
    Presas, Silvia
    Martinez-Caceres, Eva
    Ramo, Cristina
    [J]. NEUROLOGY, 2016, 86
  • [7] Effectiveness and safety profile of the natalizumab extended interval dosing in a spanish cohort
    Costa-Frossard, L.
    Sainz De La Maza, S.
    Monreal, E.
    Gomez Lopez, A.
    Fernandez-Velasco, J. I.
    Walo Delgado, P.
    Espino, M.
    Villarrubia, N.
    Masjuan, J.
    Villar, L. M.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 278 - 278
  • [8] Natalizumab extended interval dosing: efficacy and safety profile analysis from a Portuguese Multiple Sclerosis Center
    Ferreira, P.
    Oliveira, D.
    Boleixa, D.
    Ferreira, I.
    da Silva, A. Martins
    Samoes, R.
    Santos, E.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 526 - 526
  • [9] Extended-interval dosing of natalizumab in NOVA
    Stuve, Olaf
    Tugemann, Bastian
    [J]. LANCET NEUROLOGY, 2023, 22 (03): : 199 - 200
  • [10] Pharmacodynamics of natalizumab extended interval dosing in MS
    Zhovtis Ryerson, Lana
    Li, Xiaochun
    Goldberg, Judith D.
    Hoyt, Tamara
    Christensen, Angel
    Metzger, Ryan R.
    Kister, Ilya
    Foley, John
    [J]. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2020, 7 (02):
12345